2019 US Medicinal Products
Financial Strength Rankings using Artificial Intelligence
Top rated | 12 of 50 |
Best rating | 159 % |
Worst rating | -420 % |
New companies | 6 |
Negative Economic Capital Ratio | 16 of 50 |
Financial Strength Rankings using Artificial Intelligence
Top rated | 12 of 50 |
Best rating | 159 % |
Worst rating | -420 % |
New companies | 6 |
Negative Economic Capital Ratio | 16 of 50 |
TAURIGA SCIENCES INC. climbed 22 positions from 47 to 25 due to its excellent Net Income.Navidea Biopharmaceuticals Inc. lost 45 positions from 1 to 46 due to its bad Net Income.Huntsman CORP entered the 2019 ranking at rank 19, making it the best newcomer.
Revenues | 41.6 B |
Assets | 55.1 B |
Expenses | 38.6 B |
Stockholders Equity | 22.6 B |
Unprofitable Companies | 28 of 50 |
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the U.S. Petroleum [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the U.S. Aviation [...]
🚀 RealRate is raising! At realrate.ai, we’re revolutionizing financial ratings and analytics [...]
Last week, Dr. Holger Bartel, CEO of RealRate, pitched the business, showing how [...]
Earlier in September in Berlin, Dr. Holger Bartel, CEO of RealRate, hosted an [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the U.S. Life [...]
Source: https://www.germanaccelerator.com Some incredible news at RealRate, folks! We have been [...]
Last week Dr. Holger Bartel, CEO at RealRate, took part in a very [...]
This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai